Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.

about

Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.

Item

http://www.wikidata.org/entity/Q48610668

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@en

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@nl

type

Item

label

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@en

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@nl

prefLabel

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@en

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@nl

P1476

Co-delivery of hypoxia inducib ...... gastric cancer SGC-7901 cells.

@en

P2093

Dongdong Guo

http://www.w3.org/2001/XMLSchema#string

Li Sun

http://www.w3.org/2001/XMLSchema#string

Weidong Chen

http://www.w3.org/2001/XMLSchema#string

Yunna Chen

http://www.w3.org/2001/XMLSchema#string

Ziteng Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells

A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance

HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a

HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.

To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells.

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.

Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.

P31

scholarly article

P356

10.1002/JGM.2998

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106062

http://www.w3.org/2001/XMLSchema#string